Thyrocare Technologies Limited

NSE:THYROCARE.NS

831.05 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Revenue 1,569.11,542.51,347.41,4801,348.91,358.81,280.31,349.71,277.91,305.61,1741,762.11,646.41,468.31,382.71,532.5562.71,014.41,057.91,162.41,097.31,055.9962.91,038.8971.5966.55838.68880.36877.56876.71682.64787.14693.62719.31540.15622.65569.95
Cost of Revenue 855.4862384.2436.4380.7417.5408.6411.2395418.9300436.1542.1443.8427508.5259.6275.2275312.1308.6306.1259.5283.7256259.82207.63259.02223.26252.99203.59232.93203.79225.88155.68180.22173.89
Gross Profit 713.7680.5963.21,043.6968.2941.3871.7938.5882.9886.78741,3261,104.31,024.5955.71,024303.1739.2782.9850.3788.7749.8703.4755.1715.5706.73631.05621.34654.3623.72479.05554.21489.83493.43384.47442.43396.06
Gross Profit Ratio 0.4550.4410.7150.7050.7180.6930.6810.6950.6910.6790.7440.7530.6710.6980.6910.6680.5390.7290.740.7320.7190.710.7310.7270.7360.7310.7520.7060.7460.7110.7020.7040.7060.6860.7120.7110.695
Reseach & Development Expenses 0000000000000000000000000000000000000
General & Administrative Expenses 0305.6000347.1000300039.68.400011.9000130.5000134.2000151.300020.5913.0600
Selling & Marketing Expenses 0167.400064.4000530041.456.600057.5000113.7000102.800068.9800017.7212.7500
SG&A 400.9473383.7397.8344.4411.5322.7331307.283359282.9816500069.4000244.2000237000220.2800038.3125.8100
Other Expenses 36.234.927.321.79.8372116.210-25314151.9104.9-66.725.849.912.2-34.68.524.623.6-3933.42422.6108.82291.92276.8947.646.0552.82248.96235.23198.2236.28193.62229.52
Operating Expenses 400.9473782774.9719.4802.4694.6714.2609.8607.5594514.7463.7588.3537.9481.4288.2514.6423.3411406.1474.6417.1390.9360.3390.63291.92276.89334.23341.3286.07248.96235.23198.22236.3193.62229.52
Operating Income 312.8207.5209.8294248.8179.1203241.5273.1279.2280811.3640.6436.4417.8542.614.9224.6359.6439.3382.6275.2286.3364.2355.2316.1339.13344.45320.07282.42192.98305.25254.6295.21148.17248.81166.54
Operating Income Ratio 0.1990.1350.1560.1990.1840.1320.1590.1790.2140.2140.2390.460.3890.2970.3020.3540.0260.2210.340.3780.3490.2610.2970.3510.3660.3270.4040.3910.3650.3220.2830.3880.3670.410.2740.40.292
Total Other Income Expenses Net 26.323.7-10.7-11.30.2-6.7-5.8-5.47217143.194.537.323.4466.4-495.221.220.717.933.62721.1107.33-1.04-2.3826.276.0552.8243.9622.96-76.9936.2828.049.21
Income Before Tax 339.1231.2199.1282.7249172.4197.2236.1280.1300.2287954.4735.1473.7441.2588.621.3175.6364.8460.5403.3293.1319.9391.2376.3423.43338.09342.07346.34288.47245.8305.25254.6218.22184.45248.81166.54
Income Before Tax Ratio 0.2160.150.1480.1910.1850.1270.1540.1750.2190.230.2440.5420.4460.3230.3190.3840.0380.1730.3450.3960.3680.2780.3320.3770.3870.4380.4030.3890.3950.3290.360.3880.3670.3030.3410.40.292
Income Tax Expense 96.157.251.779.476.747.550.281.862.887.872177.1179.498.8117.3158.119191.689.9110128.6129.9118.4138.6142.3172.13123.4295.49126.1598.9792.01102.9490.5878.8976.3186.4558.39
Net Income 241.7177.8153.5203.3173124.9147.2154.3217.3212.4215777.3555.7374.9323.9430.52.3-16274.9350.5274.7163.2201.5252.6234251.31214.67246.58220.19189.5153.79202.31164.02139.33108.14162.36117.64
Net Income Ratio 0.1540.1150.1140.1370.1280.0920.1150.1140.170.1630.1830.4410.3380.2550.2340.2810.004-0.0160.260.3020.250.1550.2090.2430.2410.260.2560.280.2510.2160.2250.2570.2360.1940.20.2610.206
EPS 4.563.542.93.843.272.382.783.84.114.034.0514.710.517.096.138.150.04-0.35.216.735.23.093.814.74.354.684.034.594.12.91.710.223.182.642.133.282.33
EPS Diluted 4.513.542.773.843.272.381.883.84.14.024.0514.6710.487.096.128.130.04-0.35.196.715.193.093.84.694.354.664.024.584.092.91.710.223.182.642.133.282.33
EBITDA 426.4338.1344.5400.5354.1287.1304.5333371.8402.63801,042.9712.8456.1522.6668.494.2281.9447.1548.9481.5312.5390.3458.8434.2480.93390.56395.26411.9331.7292.44348.5295.92229.09230.83288.99212.08
EBITDA Ratio 0.2720.2190.2560.2710.2630.2110.2380.2470.2910.3080.3240.5920.4330.3110.3780.4360.1670.2780.4230.4720.4390.2960.4050.4420.4470.4980.4660.4490.4690.3780.4280.4430.4270.3180.4270.4640.372